And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...
A new oral PCSK9 inhibitor, enlicitide, offers a daily pill option for lowering LDL-C, a key cardiovascular disease risk ...
AFTER years of “eating her feelings” Christina Togher tipped the scales at 22 stone. Struggling to do “everyday tasks” such ...
On anti-obesity day, a transformation journey of a man who beat obesity and sleep apnea with diet, exercise and sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results